HB3344: Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine
Legislative Summary
The purpose of this bill is to establish a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the Administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
Amendments
hb3344 sfat chapman _1 4-11
hb3344 sfat chapman _1 4-11
hb3344 s hhr am _1 4-8
hb3344 s hhr am _1 4-8
hb3344 s hhr am _1 4-8 adopted
hb3344 s hhr am _1 4-8 adopted
Roll Call Votes
Status Information
Sponsors
Primary Sponsor
